Cargando…
AND-gate contrast agents for enhanced fluorescence-guided surgery
The surgical resection of tumours requires the precise location and definition of the margins between lesions and normal tissue. However, this is made difficult by irregular margin borders. Although molecularly targeted optical contrast agents can be used to define tumour margins during surgery in r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969380/ https://www.ncbi.nlm.nih.gov/pubmed/32989286 http://dx.doi.org/10.1038/s41551-020-00616-6 |
_version_ | 1783666230465396736 |
---|---|
author | Widen, John C. Tholen, Martina Yim, Joshua J. Antaris, Alexander Casey, Kerriann M. Rogalla, Stephan Klaassen, Alwin Sorger, Jonathan Bogyo, Matthew |
author_facet | Widen, John C. Tholen, Martina Yim, Joshua J. Antaris, Alexander Casey, Kerriann M. Rogalla, Stephan Klaassen, Alwin Sorger, Jonathan Bogyo, Matthew |
author_sort | Widen, John C. |
collection | PubMed |
description | The surgical resection of tumours requires the precise location and definition of the margins between lesions and normal tissue. However, this is made difficult by irregular margin borders. Although molecularly targeted optical contrast agents can be used to define tumour margins during surgery in real time, the selectivity of the contrast agents is often limited by the target being expressed in both healthy and tumour tissues. Here, we show that AND-gate optical imaging probes requiring the processing of two substrates by multiple tumour-specific enzymes produce a fluorescent signal with significantly improved specificity and sensitivity to tumour tissue. We evaluated the performance of the probes in mouse models of mammary tumours and of metastatic lung cancer, and during fluorescence-guided robotic surgery. Imaging probes relying on multivariate activation to selectively target complex patterns of enzymatic activity should be useful in disease detection, treatment and monitoring. |
format | Online Article Text |
id | pubmed-7969380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-79693802021-03-28 AND-gate contrast agents for enhanced fluorescence-guided surgery Widen, John C. Tholen, Martina Yim, Joshua J. Antaris, Alexander Casey, Kerriann M. Rogalla, Stephan Klaassen, Alwin Sorger, Jonathan Bogyo, Matthew Nat Biomed Eng Article The surgical resection of tumours requires the precise location and definition of the margins between lesions and normal tissue. However, this is made difficult by irregular margin borders. Although molecularly targeted optical contrast agents can be used to define tumour margins during surgery in real time, the selectivity of the contrast agents is often limited by the target being expressed in both healthy and tumour tissues. Here, we show that AND-gate optical imaging probes requiring the processing of two substrates by multiple tumour-specific enzymes produce a fluorescent signal with significantly improved specificity and sensitivity to tumour tissue. We evaluated the performance of the probes in mouse models of mammary tumours and of metastatic lung cancer, and during fluorescence-guided robotic surgery. Imaging probes relying on multivariate activation to selectively target complex patterns of enzymatic activity should be useful in disease detection, treatment and monitoring. 2020-09-28 2021-03 /pmc/articles/PMC7969380/ /pubmed/32989286 http://dx.doi.org/10.1038/s41551-020-00616-6 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Widen, John C. Tholen, Martina Yim, Joshua J. Antaris, Alexander Casey, Kerriann M. Rogalla, Stephan Klaassen, Alwin Sorger, Jonathan Bogyo, Matthew AND-gate contrast agents for enhanced fluorescence-guided surgery |
title | AND-gate contrast agents for enhanced fluorescence-guided surgery |
title_full | AND-gate contrast agents for enhanced fluorescence-guided surgery |
title_fullStr | AND-gate contrast agents for enhanced fluorescence-guided surgery |
title_full_unstemmed | AND-gate contrast agents for enhanced fluorescence-guided surgery |
title_short | AND-gate contrast agents for enhanced fluorescence-guided surgery |
title_sort | and-gate contrast agents for enhanced fluorescence-guided surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969380/ https://www.ncbi.nlm.nih.gov/pubmed/32989286 http://dx.doi.org/10.1038/s41551-020-00616-6 |
work_keys_str_mv | AT widenjohnc andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT tholenmartina andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT yimjoshuaj andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT antarisalexander andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT caseykerriannm andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT rogallastephan andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT klaassenalwin andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT sorgerjonathan andgatecontrastagentsforenhancedfluorescenceguidedsurgery AT bogyomatthew andgatecontrastagentsforenhancedfluorescenceguidedsurgery |